Alexa J Roeder
Overview
Explore the profile of Alexa J Roeder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roeder A, Koehler M, Jasbi P, McKechnie D, Vanderhoof J, Edwards B, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146537
COVID-19 mRNA vaccines protect against severe disease and hospitalization. Neutralizing antibodies (NAbs) are a first-line defense mechanism, but protective NAb responses are variable. Currently, NAb testing is not widely available....
2.
Kibler K, Szczerba M, Lake D, Roeder A, Rahman M, Hogue B, et al.
Vaccines (Basel)
. 2022 Jul;
10(8).
PMID: 35893821
The Omicron SARS-CoV-2 variant has been designated as a variant of concern because its spike protein is heavily mutated. In particular, the Omicron spike is mutated at five positions (K417,...
3.
Lake D, Roeder A, Gonzalez-Moa M, Koehler M, Kaleta E, Jasbi P, et al.
Commun Med (Lond)
. 2022 Jul;
2:85.
PMID: 35832309
Background: While evaluating COVID-19 vaccine responses using a rapid neutralizing antibody (NAb) test, we observed that 25% of mRNA vaccine recipients did not neutralize >50%. We termed this group "vaccine...
4.
Lake D, Roeder A, Seit-Nebi A, Gonzalez-Moa M, Svarovsky S
EBioMedicine
. 2022 Feb;
77:103898.
PMID: 35220041
No abstract available.
5.
Kibler K, Szczerba M, Lake D, Roeder A, Rahman M, Hogue B, et al.
bioRxiv
. 2021 Dec;
PMID: 34909775
The Omicron SARS-CoV-2 variant has been designated a variant of concern because its spike protein is heavily mutated. In particular, Omicron spike is mutated at 5 positions (K417, N440, E484,...
6.
Lake D, Roeder A, Kaleta E, Jasbi P, Pfeffer K, Koelbela C, et al.
J Clin Virol
. 2021 Nov;
145:105024.
PMID: 34781240
Background: After receiving a COVID-19 vaccine, most recipients want to know if they are protected from infection and for how long. Since neutralizing antibodies are a correlate of protection, we...